Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections
Under a Creative Commons license
open access
Keywords
COVID-19
Tocilizumab
COVID-19 secondary infections
COVID-19 mortality
Cited by (0)
© 2022 The Author(s). Published by Elsevier Ltd on behalf of The Healthcare Infection Society.